Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases

Overview

Journal Balkan Med J

Publisher Galenos Publishing House

Specialty General Medicine

Date 2016 Oct 21

PMID 27761284

Citations 4

Authors

Hakan Korkmaz

Suzan Tabur

Esen Savas

Mesut Ozkaya

Sefika Nur Aksoy

Nurten Aksoy

Ersin Akarsu

Affiliations

Soon will be listed here.

Abstract

Background: The correlation of S100A8/S100A9 with various inflammatory conditions, including autoimmune diseases have been reported. There is no study investigating the levels of S100A8/S100A9 in autoimmune thyroid diseases (AITD).

Aims: We aimed to evaluate the level of serum S100A8/S100A9 in AITD.

Study Design: Case control study.

Methods: Fifty patients with AITD (25 Hashimoto's thyroiditis (HT) and 25 Graves' disease (GD)) were included in the study. Twenty seven healthy subjects participated as a control group. Blood samples were obtained in the 3 months after the initiation of medical treatment. Serum levels of total antioxidant status (TAS), total oxidative status (TOS), total free sulfhydryl (SH), lipid hydroperoxide (LOOH) and S100A8/S100A9 were analyzed.

Results: The patients with AITD had significantly higher S100A8/S100A9, OSI, LOOH and TOS levels than the healthy control group. There was no significant difference between GD and HT patients in terms of S100A8/S100A9, TOS and OSI levels. S100A8/S100A9 level was positively correlated with LOOH, TOS and OSI levels but negatively correlated with -SH level in the patients with AITD.

Conclusion: Serum S100A8/S100A9 levels were increased in patients with AITD and positively correlated with LOOH, TOS and OSI whereas negatively correlated with SH.

Citing Articles

Transcriptome analysis of the effect of diosgenin on autoimmune thyroiditis in a rat model.

Zhang C, Qin L, Sun B, Wu Y, Zhong F, Wu L Sci Rep. 2021; 11(1):6401.

PMID: 33737640 PMC: 7973441. DOI: 10.1038/s41598-021-85822-1.

Circulating microRNA Expression Profiling Identifies miR-125a-5p Promoting T Helper 1 Cells Response in the Pathogenesis of Hashimoto's Thyroiditis.

Liu Y, Ding X, Xiong S, Wang X, Tang X, Wang L Front Immunol. 2020; 11:1195.

PMID: 32595646 PMC: 7300231. DOI: 10.3389/fimmu.2020.01195.

Increased Plasma Levels of S100A8, S100A9, and S100A12 in Chronic Spontaneous Urticaria.

Zhou Q, Lin W, Zhu X, Xu S, Ying M, Shi L Indian J Dermatol. 2020; 64(6):441-446.

PMID: 31896840 PMC: 6862366. DOI: 10.4103/ijd.IJD_375_18.

Aberrant MRP14 expression in thyroid follicular cells mediates chemokine secretion through the IL-1β/MAPK pathway in Hashimoto's thyroiditis.

Luo X, Zheng T, Mao C, Dong X, Mou X, Xu C Endocr Connect. 2018; 7(6):850-858.

PMID: 29764904 PMC: 6000753. DOI: 10.1530/EC-18-0019.

References

Antonelli A, Ferrari S, Corrado A, Di Domenicantonio A, Fallahi P . Autoimmune thyroid disorders. Autoimmun Rev. 2014; 14(2):174-80. DOI: 10.1016/j.autrev.2014.10.016. View

Garcia-Arias M, Pascual-Salcedo D, Ramiro S, Ueberschlag M, Jermann T, Cara C . Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort. Mol Diagn Ther. 2013; 17(1):49-56. DOI: 10.1007/s40291-013-0016-9. View

Aycicek A, Erel O, Kocyigit A . Increased oxidative stress in infants exposed to passive smoking. Eur J Pediatr. 2005; 164(12):775-8. DOI: 10.1007/s00431-005-1720-1. View

Hansson C, Eriksson C, Alenius G . S-calprotectin (S100A8/S100A9): a potential marker of inflammation in patients with psoriatic arthritis. J Immunol Res. 2014; 2014:696415. PMC: 4053083. DOI: 10.1155/2014/696415. View

Ehrchen J, Sunderkotter C, Foell D, Vogl T, Roth J . The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 2009; 86(3):557-66. DOI: 10.1189/jlb.1008647. View

Rostami R, Aghasi M, Mohammadi A, Nourooz-Zadeh J . Enhanced oxidative stress in Hashimoto's thyroiditis: inter-relationships to biomarkers of thyroid function. Clin Biochem. 2012; 46(4-5):308-12. DOI: 10.1016/j.clinbiochem.2012.11.021. View

van Bon L, Cossu M, Loof A, Gohar F, Wittkowski H, Vonk M . Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype. Ann Rheum Dis. 2014; 73(8):1585-9. DOI: 10.1136/annrheumdis-2013-205013. View

Erel O . A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005; 38(12):1103-11. DOI: 10.1016/j.clinbiochem.2005.08.008. View

Lassoued S, Mseddi M, Mnif F, Abid M, Guermazi F, Masmoudi H . A comparative study of the oxidative profile in Graves' disease, Hashimoto's thyroiditis, and papillary thyroid cancer. Biol Trace Elem Res. 2010; 138(1-3):107-15. DOI: 10.1007/s12011-010-8625-1. View

10.

Tyden H, Lood C, Gullstrand B, Jonsen A, Nived O, Sturfelt G . Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. Rheumatology (Oxford). 2013; 52(11):2048-55. DOI: 10.1093/rheumatology/ket263. View

11.

Striz I, Trebichavsky I . Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004; 53(3):245-53. View

12.

Komosinska-Vassev K, Olczyk K, Kucharz E, Marcisz C, Winsz-Szczotka K, Kotulska A . Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta. 2000; 300(1-2):107-17. DOI: 10.1016/s0009-8981(00)00306-5. View

13.

Zarkovic M . The role of oxidative stress on the pathogenesis of graves' disease. J Thyroid Res. 2011; 2012:302537. PMC: 3235898. DOI: 10.1155/2012/302537. View

14.

Arab K, Steghens J . Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem. 2004; 325(1):158-63. DOI: 10.1016/j.ab.2003.10.022. View

15.

Poncin S, Van Eeckoudt S, Humblet K, Colin I, Gerard A . Oxidative stress: a required condition for thyroid cell proliferation. Am J Pathol. 2010; 176(3):1355-63. PMC: 2832155. DOI: 10.2353/ajpath.2010.090682. View

16.

Ellman G . Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82(1):70-7. DOI: 10.1016/0003-9861(59)90090-6. View

17.

Cerezo L, Mann H, Pecha O, Plestilova L, Pavelka K, Vencovsky J . Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther. 2011; 13(4):R122. PMC: 3239361. DOI: 10.1186/ar3426. View

18.

Lim S, Raftery M, Goyette J, Hsu K, Geczy C . Oxidative modifications of S100 proteins: functional regulation by redox. J Leukoc Biol. 2009; 86(3):577-87. DOI: 10.1189/jlb.1008608. View

19.

Schiopu A, Cotoi O . S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediators Inflamm. 2014; 2013:828354. PMC: 3881579. DOI: 10.1155/2013/828354. View

20.

Erel O . A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004; 37(2):112-9. DOI: 10.1016/j.clinbiochem.2003.10.014. View